β¨ Medicines Distribution Consent
27 JULY NEW ZEALAND GAZETTE 2035
Product: Zytram SR
Active Ingredient(s): Tramadol hydrochloride 200mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: Zytram SR
Active Ingredient(s): Tramadol hydrochloride 75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: Zytram XL
Active Ingredient(s): Tramadol hydrochloride 150mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: Zytram XL
Active Ingredient(s): Tramadol hydrochloride 200mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: Zytram XL
Active Ingredient(s): Tramadol hydrochloride 300mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Product: Zytram XL
Active Ingredient(s): Tramadol hydrochloride 400mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Bard Pharmaceuticals Limited, Cambridge, United Kingdom
Dated this 19th day of July 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5366
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Dysport
Active Ingredient(s): Clostridium botulinum type A toxin haemagglutinin complex 500U
Dosage Form: Powder for injection
New Zealand Sponsor: New Zealand Medical & Scientific Limited
Manufacturer(s): Ispen Limited, Clwyd, United Kingdom
Product: Singulair
Active Ingredient(s): Montelukast sodium 5.2mg equivalent to 5mg montelukast free acid
Dosage Form: Chewable tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 84
Gazette.govt.nz —
NZ Gazette 2000, No 84
β¨ LLM interpretation of page content
π₯
Consent to Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare19 July 2000
Medicines, Distribution Consent, Tramadol hydrochloride, Zytram SR, Zytram XL
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines, Distribution Consent, Clostridium botulinum type A toxin, Montelukast sodium, Dysport, Singulair